Company Filing History:
Years Active: 1999-2005
Title: **Stephen E. Hughes: Innovator in Retinal Surgery**
Introduction
Stephen E. Hughes, located in Delmar, NY, is a remarkable inventor specializing in surgical innovations related to retinal procedures. With a total of four patents to his name, Hughes has made significant contributions to the field of ophthalmic surgery, enhancing the methods of treating retinal disorders.
Latest Patents
One of Hughes' latest patents is for **retinal cell grafts**, which details surgical instruments and techniques for the isolation and transplantation of retinal cells, including photoreceptors and retinal pigment epithelium. This innovation allows for not only the preservation of the tissues' natural configuration but also the possibility of co-transplantation of these three crucial components.
Another notable patent is the **instrument for subretinal implantation**. This device consists of an elongated tube with a lumen that facilitates the precise implantation of materials beneath the retina. Its design includes a plunger capable of expressing materials through an opening in the tip of the tube, ensuring that the delivery of therapeutic agents or cells occurs effectively within the subretinal space.
Career Highlights
Stephen E. Hughes is currently associated with Photogenesis, Inc., where he continues to develop innovative solutions aimed at enhancing retinal surgery outcomes. His work demonstrates a deep commitment to advancing medical techniques and improving patient care in ophthalmology.
Collaborations
Throughout his career, Hughes has likely collaborated with various professionals and researchers in the field of ophthalmology. These partnerships have undoubtedly played a vital role in the refinement and implementation of his inventive surgical techniques and instruments, contributing to a collective effort to advance the state of retinal therapies.
Conclusion
Stephen E. Hughes stands out as an influential inventor in the realm of retinal surgery. His innovative patents not only reflect his expertise but also signify a positive impact on the medical community's approach to treating eye disorders. As he continues his work with Photogenesis, Inc., the future of retinal therapies looks promising, thanks to inventors like him.